The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:

Policy Notices

• Supplemental Information to the NIH Policy for Data Management and Sharing: Protecting Privacy When Sharing Human Research Participant Data
  (NOT-OD-22-213)
  Office of the Director, NIH

• Supplemental Information to the NIH Policy for Data Management and Sharing: Responsible Management and Sharing of American Indian/Alaska Native Participant Data
  (NOT-OD-22-214)
  Office of the Director, NIH

• NIH Final Federal Financial Reports (FFRs) will no longer be converted to Interim Annual Reports in the Payment Management System
  (NOT-OD-22-215)
  National Institutes of Health

General Notices

• Notice of NIDDK Participation in RFA-EB-22-002 "HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)"
  (NOT-DK-22-030)
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice Announcing Frequently Asked Questions (FAQs) for the Maternal Health Centers of Excellence Funding Opportunity Announcements
  (NOT-HD-22-048)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development

• Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-22-240, "BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)"
  (NOT-MH-22-315)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke

• Notice of Information: Announcing NIH Community Partnerships to Advance Science for Society (ComPASS) Program: Community-Led, Health Equity Structural Intervention Initiative (CHESI) Research Opportunity Announcement (ROA) and Technical Assistance Webinar
  (NOT-RM-23-004)
  Office of Strategic Coordination (Common Fund)

Notice of Changes to Funding Opportunities

• Notice of Change to Key Dates to PAS-22-197, "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)"
  (NOT-AG-22-038)
  National Institute on Aging

• Notice of Early Expiration of PAR-21-335 "Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)"
  (NOT-CA-22-128)
  National Cancer Institute

• Notice of Budget Language Change in RFA-HL-23-016 "New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)"
  (NOT-HL-22-044)
  National Heart, Lung, and Blood Institute
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke

• Notice of Budget Language Change in RFA-HL-23-015 "New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)"
  (NOT-HL-22-047)
  National Heart, Lung, and Blood Institute
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke

• Notice of Change to Key Dates for PAR-22-181 "NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
  (NOT-NS-23-027)
  National Institute of Neurological Disorders and Stroke

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed)
  (NOT-CA-22-126)
  National Cancer Institute

• Notice of Intent to Publish a Funding Opportunity Announcement for Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24)
  (NOT-OD-22-216)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

• Notice of Intent to Publish a Funding Opportunity Announcement for Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01)
  (NOT-OD-22-217)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Notices of Special Interest

• Notice of Special Interest (NOSI): Halting Tuberculosis (TB) Transmission
  (NOT-AI-22-064)
  National Institute of Allergy and Infectious Diseases

• Notice of Special Interest (NOSI): Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE initiative
  (NOT-HD-22-043)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of AIDS Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Dietary Supplements
  Office of Research on Women's Health

Funding Opportunities

• AHRQ Mentored Research Scientist Career Development Award (K01)
  (PA-22-255)
  Agency for Healthcare Research and Quality
   
• Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R21 Clinical Trial Not Allowed)
  (PAR-22-236)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
   
• Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R01 Clinical Trial Not Allowed)
  (PAR-22-237)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
   
• NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
  (PAR-22-241)
  National Institute of Allergy and Infectious Diseases
   
• Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)
  (RFA-AI-22-059)
  National Institute of Allergy and Infectious Diseases
   
• Large Scale Integrated Mapping and Molecular Profiling of Cell Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed)
  (RFA-DA-23-035)
  National Institute on Drug Abuse
   
• BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
  (RFA-DA-23-039)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
   
• HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional)
  (RFA-DA-23-057)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
   
• HEAL Initiative: HEAL Data2Action Acceleration Projects (R33 Clinical Trial Not Allowed)
  (RFA-DA-23-058)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
   
• Diversity Centers for Genome Research (U54 Clinical Trials Optional)
  (RFA-HG-22-026)
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
   
• Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)
  (RFA-HG-22-027)
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
   
• Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
  (RFA-MH-22-270)
  National Institute of Mental Health
   
• Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
  (RFA-MH-22-271)
  National Institute of Mental Health
   
• Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) (U01 Clinical Trial Not Allowed)
  (RFA-NS-22-029)
  National Institute of Neurological Disorders and Stroke
   
• Data Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - DCC) (U01 Clinical Trial Not Allowed)
  (RFA-NS-22-030)
  National Institute of Neurological Disorders and Stroke
   
• Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)
  (RFA-NS-22-031)
  National Institute of Neurological Disorders and Stroke
   
• Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (UT1, UT2 Clinical Trail Not Allowed)
  (RFA-TR-22-031)
  National Center for Advancing Translational Sciences
  National Institute of Neurological Disorders and Stroke
   
• Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (U43/U44 - Clinical Trail Not Allowed)
  (RFA-TR-22-032)
  National Center for Advancing Translational Sciences
  National Institute of Neurological Disorders and Stroke
   

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail)  or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail).